NVAX

NVAX Stock-Based Compensation

$32.33MTTM · USD

Period ending:

NVAX FY Stock-Based CompUSD
NVAX FY Stock-Based Comp1996-12-31: $0.001997-12-31: $0.001998-12-31: $0.001999-12-31: $0.002000-12-31: $0.002001-12-31: $0.002002-12-31: $108.00K2003-12-31: $0.002004-12-31: $53.00K2005-12-31: $406.00K2006-12-31: $2.27M2007-12-31: $1.80M2008-12-31: $2.07M2009-12-31: $1.53M2010-12-31: $1.34M2011-12-31: $2.05M2012-12-31: $2.09M2013-12-31: $2.48M2014-12-31: $6.09M2015-12-31: $13.43M2016-12-31: $19.16M2017-12-31: $19.81M2018-12-31: $18.31M2019-12-31: $17.05M2020-12-31: $128.04M2021-12-31: $183.63M2022-12-31: $130.30M2023-12-31: $85.36M2024-12-31: $48.15M2025-12-31: $36.02M$183.63M$0.00
1996-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

NVAX stock-based compensation history

Non-cash compensation expense paid in equity. The available annual fiscal periods series contains 30 observations from Dec 31, 1996 to Dec 31, 2025.

Novavax Inc Stock-Based Compensation — Annual fiscal periods (USD)
Period endingStock-Based Compensation (USD)
36,015,000
48,152,000
85,357,000
130,300,000
183,626,000
128,035,000
17,048,000
18,314,000
19,809,000
19,160,000
13,431,000
6,090,000
2,480,000
2,091,000
2,047,000
1,339,000
1,533,000
2,070,000
1,800,000
2,267,000
406,000
53,000
0
108,000
0
0
0
0
0
0

Compare stock-based compensation

All NVAX financial metrics · NVAX stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.